Abiopharma

Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025

Announcement relating to despatch of Rule 15 proposal

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Levi & Korsinsky Notifies Perrigo Company plc Investors of a Class Action Lawsuit and Upcoming Deadline - PRGO

Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 - DXCM

Shareholders that lost money on Inspire Medical Systems, Inc.(INSP) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Baxter International, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BAX

How to Turn on Location on iPhone

Latest About Meta Quest 3: What You Need to Know in 2026